Leading the Change: Transforming Psychedelic Healthcare Through Harm Reduction Practices

  • 📰 RollingStone
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 51%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Applying harm reduction to treatment allows clinicians to meet individuals where they are and provide support to mitigate potential harm.

Content created by members of Rolling Stone Culture Council Rolling Stone Culture Council is an invitation-only network of industry professionals who share their insights with our audience.Opinions expressed are solely those of the author and do not reflect the views of Rolling Stone editors or publishers.

Psychedelic medicines such as Ketamine, MDMA, LSD, Psilocybin , Ayuasca and Ibogaine have gained the interest of many professional healers, as well as many mental health sufferers, due to their profound ability to shift perspectives and improve difficult symptoms related to various mental health conditions. However, similar to psychotropic medicines, psychedelic medicines have strong effects.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 483. in HEALTH

Health Health Latest News, Health Health Headlines